Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs

Overview

Journal Toxics

Date 2022 Mar 24

PMID 35324771

Authors

Julia Malits

Mrudula Naidu

Leonardo Trasande

Affiliations

Soon will be listed here.

Abstract

Exposure to endocrine-disrupting chemicals (EDCs) contributes to substantial disease burden worldwide. We aim to quantify the disease burden and costs of EDC exposure in Canada and to compare these results with previously published findings in the European Union (EU) and United States (US). EDC biomonitoring data from the Canadian Health Measures Survey (2007-2011) was applied to 15 exposure-response relationships, and population and cost estimates were based on the 2010 general Canadian population. EDC exposure in Canada (CAD 24.6 billion) resulted in substantially lower costs than the US (USD 340 billion) and EU (USD 217 billion). Nonetheless, our findings suggest that EDC exposure contributes to substantial and costly disease burden in Canada, amounting to 1.25% of the annual Canadian gross domestic product. As in the US, exposure to polybrominated diphenyl ethers was the greatest contributor of costs (8.8 billion for 374,395 lost IQ points and 2.6 billion for 1610 cases of intellectual disability). In the EU, organophosphate pesticides were the largest contributor to costs (USD 121 billion). While the burden of EDC exposure is greater in the US and EU, there remains a similar need for stronger EDC regulatory action in Canada beyond the current framework of the Canadian Environmental Protection Act of 1999.

Citing Articles

The benefits of removing toxic chemicals from plastics.

Cropper M, Dunlop S, Hinshaw H, Landrigan P, Park Y, Symeonides C Proc Natl Acad Sci U S A. 2024; 121(52):e2412714121.

PMID: 39680769 PMC: 11670057. DOI: 10.1073/pnas.2412714121.

Endocrine-disrupting chemicals: Mainstream recognition of health effects and implications for the practicing internist.

Trasande L, Sargis R J Intern Med. 2023; 295(2):259-274.

PMID: 38037246 PMC: 11457725. DOI: 10.1111/joim.13748.

The regulation of endocrine-disrupting chemicals to minimize their impact on health.

Duh-Leong C, Maffini M, Kassotis C, Vandenberg L, Trasande L Nat Rev Endocrinol. 2023; 19(10):600-614.

PMID: 37553404 DOI: 10.1038/s41574-023-00872-x.

The Minderoo-Monaco Commission on Plastics and Human Health.

Landrigan P, Raps H, Cropper M, Bald C, Brunner M, Canonizado E Ann Glob Health. 2023; 89(1):23.

PMID: 36969097 PMC: 10038118. DOI: 10.5334/aogh.4056.

An Analysis of the Structural Relationship between Thyroid Hormone-Signaling Disruption and Polybrominated Diphenyl Ethers: Potential Implications for Male Infertility.

Sheikh I, Beg M, Hamoda T, Mandourah H, Memili E Int J Mol Sci. 2023; 24(4).

PMID: 36834711 PMC: 9964322. DOI: 10.3390/ijms24043296.

References

. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003. MMWR Morb Mortal Wkly Rep. 2004; 53(3):57-9. View

Haines D, Saravanabhavan G, Werry K, Khoury C . An overview of human biomonitoring of environmental chemicals in the Canadian Health Measures Survey: 2007-2019. Int J Hyg Environ Health. 2016; 220(2 Pt A):13-28. DOI: 10.1016/j.ijheh.2016.08.002. View

Trasande L, Zoeller R, Hass U, Kortenkamp A, Grandjean P, Myers J . Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab. 2015; 100(4):1245-55. PMC: 4399291. DOI: 10.1210/jc.2014-4324. View

Main K, Kiviranta H, Virtanen H, Sundqvist E, Tuomisto J, Tuomisto J . Flame retardants in placenta and breast milk and cryptorchidism in newborn boys. Environ Health Perspect. 2007; 115(10):1519-26. PMC: 2022640. DOI: 10.1289/ehp.9924. View

Do M, Chang V, Mendez M, de Groh M . Urinary bisphenol A and obesity in adults: results from the Canadian Health Measures Survey. Health Promot Chronic Dis Prev Can. 2017; 37(12):403-412. PMC: 5765817. DOI: 10.24095/hpcdp.37.12.02. View

de Oliveira C, Pataky R, Bremner K, Rangrej J, Chan K, Cheung W . Phase-specific and lifetime costs of cancer care in Ontario, Canada. BMC Cancer. 2016; 16(1):809. PMC: 5070134. DOI: 10.1186/s12885-016-2835-7. View

Valvi D, Casas M, Mendez M, Ballesteros-Gomez A, Luque N, Rubio S . Prenatal bisphenol a urine concentrations and early rapid growth and overweight risk in the offspring. Epidemiology. 2013; 24(6):791-9. DOI: 10.1097/EDE.0b013e3182a67822. View

Attina T, Hauser R, Sathyanarayana S, Hunt P, Bourguignon J, Myers J . Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. 2016; 4(12):996-1003. DOI: 10.1016/S2213-8587(16)30275-3. View

Trasande L, Chatterjee S . The impact of obesity on health service utilization and costs in childhood. Obesity (Silver Spring). 2009; 17(9):1749-54. DOI: 10.1038/oby.2009.67. View

10.

Trasande L, Zoeller R, Hass U, Kortenkamp A, Grandjean P, Myers J . Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016; 4(4):565-72. PMC: 5244983. DOI: 10.1111/andr.12178. View

11.

Iszatt N, Stigum H, Verner M, White R, Govarts E, Murinova L . Prenatal and Postnatal Exposure to Persistent Organic Pollutants and Infant Growth: A Pooled Analysis of Seven European Birth Cohorts. Environ Health Perspect. 2015; 123(7):730-6. PMC: 4492262. DOI: 10.1289/ehp.1308005. View

12.

Song Y, Hauser R, Hu F, Franke A, Liu S, Sun Q . Urinary concentrations of bisphenol A and phthalate metabolites and weight change: a prospective investigation in US women. Int J Obes (Lond). 2014; 38(12):1532-7. PMC: 4481130. DOI: 10.1038/ijo.2014.63. View

13.

Meeker J, Ferguson K . Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011-2012. J Clin Endocrinol Metab. 2014; 99(11):4346-52. PMC: 4223430. DOI: 10.1210/jc.2014-2555. View

14.

Hodgson T, Meiners M . Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc. 1982; 60(3):429-62. View

15.

Vasiliadis H, Diallo F, Rochette L, Smith M, Langille D, Lin E . Temporal Trends in the Prevalence and Incidence of Diagnosed ADHD in Children and Young Adults between 1999 and 2012 in Canada: A Data Linkage Study. Can J Psychiatry. 2017; 62(12):818-826. PMC: 5714116. DOI: 10.1177/0706743717714468. View

16.

Shaffer R, Sellers S, Baker M, de Buen Kalman R, Frostad J, Suter M . Improving and Expanding Estimates of the Global Burden of Disease Due to Environmental Health Risk Factors. Environ Health Perspect. 2019; 127(10):105001. PMC: 6867191. DOI: 10.1289/EHP5496. View

17.

Gascon M, Vrijheid M, Martinez D, Forns J, Grimalt J, Torrent M . Effects of pre and postnatal exposure to low levels of polybromodiphenyl ethers on neurodevelopment and thyroid hormone levels at 4 years of age. Environ Int. 2011; 37(3):605-11. DOI: 10.1016/j.envint.2010.12.005. View

18.

Beausoleil C, Emond C, Cravedi J, Antignac J, Applanat M, Appenzeller B . Regulatory identification of BPA as an endocrine disruptor: Context and methodology. Mol Cell Endocrinol. 2018; 475:4-9. DOI: 10.1016/j.mce.2018.02.001. View

19.

Monteiro P, Victora C . Rapid growth in infancy and childhood and obesity in later life--a systematic review. Obes Rev. 2005; 6(2):143-54. DOI: 10.1111/j.1467-789X.2005.00183.x. View

20.

Rissman E, Adli M . Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinology. 2014; 155(8):2770-80. PMC: 4098001. DOI: 10.1210/en.2014-1123. View